Hedge Fund and Insider Trading News: Warren Buffett, Dan Loeb, AQR Capital Management, PayMeOn Inc (PAYM), Legacy Reserves LP Unit (LGCY), Telaria Inc (TLRA), and More

Page 2 of 2

Insider Buying: PayMeOn Inc (OTCMKTS:PAYM) Director Acquires 666,666 Shares of Stock (FairFieldCurrent.com)
PayMeOn Inc (OTCMKTS:PAYM) Director Ronald Joseph Sr. Loricco acquired 666,666 shares of the business’s stock in a transaction on Friday, August 17th. The stock was purchased at an average cost of $0.08 per share, with a total value of $53,333.28. The acquisition was disclosed in a legal filing with the SEC.

Insider Buying: Legacy Reserves LP Unit (LGCY) Major Shareholder Acquires 119,099 Shares of Stock (XNewsPress.com)
Legacy Reserves LP Unit (NASDAQ:LGCY) major shareholder Baines Creek Capital, Llc bought 119,099 shares of the stock in a transaction that occurred on Thursday, August 16th. The shares were purchased at an average cost of $4.51 per share, with a total value of $537,136.49. The acquisition was disclosed in a filing with the SEC.

Insider Buying: Appliance Recycling Centers of Amer Inc (ARCI) CFO Purchases 30,000 Shares of Stock (MaconDaily.com)
Appliance Recycling Centers of Amer Inc (NASDAQ:ARCI) CFO Virland A. Johnson acquired 30,000 shares of the business’s stock in a transaction dated Wednesday, August 29th. The stock was acquired at an average price of $1.00 per share, for a total transaction of $30,000.00. Following the completion of the transaction, the chief financial officer now owns 260,000 shares in the company, valued at approximately $260,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Insider Selling: Telaria Inc (TLRA) Major Shareholder Sells 113,062 Shares of Stock (FairFieldCurrent.com)
Telaria Inc (NYSE:TLRA) major shareholder Vii Lp Canaan sold 113,062 shares of the business’s stock in a transaction that occurred on Monday, August 20th. The shares were sold at an average price of $3.53, for a total value of $399,108.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Insider Buying: Obalon Therapeutics Inc (OBLN) Director Buys $99,999.90 in Stock (XNewsPress.com)
Obalon Therapeutics Inc (NASDAQ:OBLN) Director Kim P. Kamdar acquired 54,945 shares of Obalon Therapeutics stock in a transaction on Thursday, August 23rd. The shares were purchased at an average cost of $1.82 per share, with a total value of $99,999.90. The acquisition was disclosed in a document filed with the Securities & Exchange Commission.

Page 2 of 2